Cardiometabolic risk factors are influenced by Stearoyl‐CoA Desaturase (SCD) −1 gene polymorphisms and n‐3 polyunsaturated fatty acid supplementation
- 23 December 2013
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 58 (5) , 1079-1086
Abstract
Scope To determine if single nucleotide polymorphisms (SNPs) in stearoyl-CoA desaturase (SCD)-1 gene that encodes a key enzyme for fatty acid metabolism are associated with the response of cardiometabolic risk factors to n-3 PUFA supplementation. Methods and results Two hundred and ten subjects completed a 2-week run-in period followed by 6-week supplementation with 5 g of fish oil (1.9–2.2 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid). Risk factors were measured pre and post n-3 supplementation. Fatty acid composition of plasma phospholipids was analyzed by GC and the desaturase indices SCD16 (16:1n-7/16:0) and SCD18 (18:1n-9/18:0) were calculated. Genotyping of eight SNPs of the SCD1 gene was performed. N-3 PUFA supplementation decreased plasma triglycerides, as well as SCD16 and SCD18 indices, but increased fasting plasma glucose concentrations. SNPs in SCD1-modified cardiometabolic risk factors pre and post n-3 PUFA supplementation: triglyceride (rs508384, p = 0.0086), IL6 (rs3071, p = 0.0485), C-reactive protein (rs3829160, p = 0.0489), and SCD18 indices (rs2234970, p = 0.0337). A significant interaction effect between the SNP and n-3 PUFA supplementation was also observed for fasting plasma glucose levels (rs508384, p = 0.0262). Conclusion These results suggest that cardiometabolic risk factors are modulated by genetic variations in the SCD1 gene alone or in combination with n-3 PUFA supplementation.Keywords
This publication has 33 references indexed in Scilit:
- Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic Caucasian populationThe Journal of Nutritional Biochemistry, 2013
- Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammationMolecular Genetics and Metabolism, 2012
- Stearic acid content of abdominal adipose tissues in obese womenNutrition & Diabetes, 2012
- Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: Positive association with non-fasting plasma triglyceride levelsProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- Genetic Variation in Stearoyl-CoA Desaturase 1 Is Associated with Metabolic Syndrome Prevalence in Costa Rican AdultsThe Journal of Nutrition, 2011
- Genetic variation in lipid desaturases and its impact on the development of human diseaseLipids in Health and Disease, 2010
- Individual Stearoyl-CoA Desaturase 1 Expression Modulates Endoplasmic Reticulum Stress and Inflammation in Human Myotubes and Is Associated With Skeletal Muscle Lipid Storage and Insulin Sensitivity In VivoDiabetes, 2009
- Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From AtherosclerosisCirculation, 2008
- Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistanceJournal of Clinical Investigation, 2006
- Transcriptional Control of the Stearoyl-CoA Desaturase-1 Gene by Polyunsaturated Fatty Acids1Biochemical and Biophysical Research Communications, 1994